APA
Fader A. N., Roque D. M., Siegel E., Buza N., Hui P., Abdelghany O., Chambers S. K., Secord A. A., Havrilesky L., O'Malley D. M., Backes F., Nevadunsky N., Edraki B., Pikaart D., Lowery W., ElSahwi K. S., Celano P., Bellone S., Azodi M., Litkouhi B., Ratner E., Silasi D., Schwartz P. E. & Santin A. D. (20191003). Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Fader Amanda N, Roque Dana M, Siegel Eric, Buza Natalia, Hui Pei, Abdelghany Osama, Chambers Setsuko K, Secord Angeles Alvarez, Havrilesky Laura, O'Malley David M, Backes Floor, Nevadunsky Nicole, Edraki Babak, Pikaart Dirk, Lowery William, ElSahwi Karim S, Celano Paul, Bellone Stefania, Azodi Masoud, Litkouhi Babak, Ratner Elena, Silasi Dan-Arin, Schwartz Peter E and Santin Alessandro D. 20191003. Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Fader A. N., Roque D. M., Siegel E., Buza N., Hui P., Abdelghany O., Chambers S. K., Secord A. A., Havrilesky L., O'Malley D. M., Backes F., Nevadunsky N., Edraki B., Pikaart D., Lowery W., ElSahwi K. S., Celano P., Bellone S., Azodi M., Litkouhi B., Ratner E., Silasi D., Schwartz P. E. and Santin A. D. (20191003). Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Fader Amanda N, Roque Dana M, Siegel Eric, Buza Natalia, Hui Pei, Abdelghany Osama, Chambers Setsuko K, Secord Angeles Alvarez, Havrilesky Laura, O'Malley David M, Backes Floor, Nevadunsky Nicole, Edraki Babak, Pikaart Dirk, Lowery William, ElSahwi Karim S, Celano Paul, Bellone Stefania, Azodi Masoud, Litkouhi Babak, Ratner Elena, Silasi Dan-Arin, Schwartz Peter E and Santin Alessandro D. Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20191003.